Literature DB >> 12096713

Activation of Pyk2/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases.

Takeshi Nakamura1, Hiroshi Yamashita, Yoshito Nagano, Tetsuya Takahashi, Shalom Avraham, Hava Avraham, Masayasu Matsumoto, Shigenobu Nakamura.   

Abstract

alpha-Synuclein (alpha S) is a neuronal protein that has been implicated in the pathogenesis of Parkinson's disease. The present report demonstrates that the protein tyrosine kinase Pyk2/RAFTK is involved in cell stress-induced tyrosine phosphorylation of alpha S. Hyperosmotic stress induced tyrosine phosphorylation of alpha S via Pyk2/RAFTK at tyrosine residue 125. Pyk2/RAFTK-mediated phosphorylation of alpha S was primarily achieved with Src-family kinases. In addition, osmotic stress-induced phosphorylation of alpha S was dependent on Pyk2/RAFTK activation. Accordingly, such results indicate that Pyk2/RAFTK lies upstream of Src-family kinases in the signaling cascade by which osmotic stress induces tyrosine phosphorylation of alpha S.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096713     DOI: 10.1016/s0014-5793(02)02861-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Alpha-synuclein and dopamine metabolism.

Authors:  Shun Yu; Kenji Uéda; Piu Chan
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

2.  Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments.

Authors:  Lucy L Liu; Katherine J Franz
Journal:  J Biol Inorg Chem       Date:  2006-11-03       Impact factor: 3.358

Review 3.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

4.  A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.

Authors:  Woo-Young Kim; Dong Jo Chang; Bryan Hennessy; Hae Jin Kang; Jakyung Yoo; Seung-Ho Han; Yoo-Shin Kim; Hyun-Ju Park; Seung-Yong Seo; Seung-Yong Geo; Gordon Mills; Kyu-Won Kim; Waun Ki Hong; Young-Ger Suh; Ho-Young Lee
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

5.  Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: α-synuclein phosphorylation at tyrosine 125.

Authors:  Mirva Hejjaoui; Sara Butterfield; Bruno Fauvet; Filip Vercruysse; Jia Cui; Igor Dikiy; Michel Prudent; Diana Olschewski; Yan Zhang; David Eliezer; Hilal A Lashuel
Journal:  J Am Chem Soc       Date:  2012-03-13       Impact factor: 15.419

Review 6.  Molecular regulation of osteoclast activity.

Authors:  Angela Bruzzaniti; Roland Baron
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

7.  C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.

Authors:  Alexandra Kleinknecht; Blagovesta Popova; Diana F Lázaro; Raquel Pinho; Oliver Valerius; Tiago F Outeiro; Gerhard H Braus
Journal:  PLoS Genet       Date:  2016-06-24       Impact factor: 5.917

8.  Ganglioside Metabolism and Parkinson's Disease.

Authors:  John Forsayeth; Piotr Hadaczek
Journal:  Front Neurosci       Date:  2018-02-05       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.